NDC 61755-013

Evkeeza

Evinacumab

Evkeeza is a Intravenous Injection, Solution, Concentrate in the Human Prescription Drug category. It is labeled and distributed by Regeneron Pharmaceuticals, Inc.. The primary component is Evinacumab.

• Product ID: 61755-013_316a2495-6f62-4997-87db-0555b219fe23
• NDC: 61755-013
• Product Type: Human Prescription Drug
• Proprietary Name: Evkeeza
• Generic Name: Evinacumab
• Dosage Form: Injection, Solution, Concentrate
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2021-02-11
• Marketing Category: BLA / BLA
• Application Number: BLA761181
• Labeler Name: Regeneron Pharmaceuticals, Inc.
• Substance Name: EVINACUMAB
• Active Ingredient Strength: 150 mg/mL
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 61755-013-01

1 VIAL, SINGLE-USE in 1 CARTON (61755-013-01) > 2.3 mL in 1 VIAL, SINGLE-USE

• Marketing Start Date: 2021-02-11
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "Evkeeza" or generic name "Evinacumab"

NDC	Brand Name	Generic Name
61755-010	Evkeeza	evinacumab
61755-013	Evkeeza	evinacumab